Skip to content

Calcium Role in the Excitation-Contraction and Excitation-Transcription Coupling Processes in Human Atrial Fibrillation.

Calcium Role in the Excitation-Contraction and Excitation-Transcription Coupling Processes in Human Atrial Fibrillation. - Excitation-Contraction and Excitation-Transcription Coupling in AF.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38277
Enrollment
570
Registered
2010-06-15
Start date
2011-03-14
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial arrhythmia. Atrial fibrillation

Interventions

None listed

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients in sinus rythm and undergoing for openchest surgery. Male and female patients over 18 years old. Patients with paroxysmal AF and undergoing for openchest surgery. Patients with persistent AF and undergoing for openchest surgery. Patients who have given written consent.

Exclusion criteria

Exclusion criteria: Patients who are scheduled for re-operation. Male and female patients under 18 years old. Patients who do not speak/understand Dutch. Patients who are not will-competent.

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: 1/. To identify new cellular proarrhythmic mechanisms. 2/. To identify new nuclear targets for therapy (i.e. important factors involved in Ca2+-dependent transcription pathways).

Secondary

MeasureTime frame
The knowledge of the cellular mechanisms activated during persistent AF will significantly enhance the chances of better treatment to not only cardioconvert AF, but also to allow the atrial cells to recuperate their function after AF. This is expected to reduce the thromboembolic risks and improve cardiac function after cardioversion of AF.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)